This single, longer-acting R-enantiomer of the racemic modafinil has been approved as a wakefulness-promoting drug.
Peter Millin, PharmD Candidate
Advertisement
Articles by Peter Millin, PharmD Candidate
Advertisement
Latest Updated Articles
- Rx Product News: Profile: A Closer Look at New FDA Actions: Nuvigil
Published: June 1st 2008 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
MFN, DTC, and the Policy Pressure Cooker: Reshaping the US Drug Market
2
Eli Lilly, Novo Nordisk Strike MFN Deals With Trump Administration to Lower GLP-1 Prices
3
Oral Semaglutide Shows Promise for Weight Loss and Cardiometabolic Health
4
FDA Approves Lumateperone With Antidepressant Use for Major Depressive Disorder
5
